Bioanalysis · 2015 · 31 citations · 14 references
PharmacyPharmaceutical AnalysisPharmacologyImmunopharmacologyImmunotechnologyPharmacokinetic VariabilityBioanalytical Method ValidationImmunosuppressionImmunosuppressive AgentsImmunosuppressive TherapyAcceptance CriteriaDesorptionDesorption Temperature OptimizationMaterial Acceptance CriteriaMethod RepeatabilityQuantitative BioanalysisTemperature-programmed Desorption
BACKGROUND: We applied our concept for automated flow-through desorption of DBS to investigate the effect of desorption temperature on recovery. For this purpose, a method has been developed for the determination of four immunosuppressants in DBS. RESULTS: We compared recoveries of four immunosuppressants for measurements with and without temperature-enhanced desorption at different hematocrit (Ht) levels. Temperature-enhanced desorption increased recovery substantially for tacrolimus, sirolimus and everolimus at all Ht values and for cyclosporine At high Ht. In addition, recovery became largely independent from Ht variations. Under the optimized conditions, a brief validation using spiked blood samples showed that the method complies with acceptance criteria for quantitative bioanalysis. CONCLUSION: This method enables a quantitative analysis of immunosuppressants in DBS independent from the Ht.
14
Uwe Christians, Wolfgang Jacobsen, Natalie J. Serkova et al. · Journal of Chromatography B Biomedical Sciences and Applications · 2000 · 169 citations
Remco A. Koster, Jan‐Willem C. Alffenaar, Ben Greijdanus et al. · Talanta · 2013 · 140 citations